$0.151 0.0 0.0%
Last Trade - 04/03/21
| Market Cap | £2.18m |
| Enterprise Value | £2.18m |
| Revenue | £816k |
| Position in Universe | 6454th / 6651 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 31st Mar | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021E | 2022E | CAGR / Avg | |
|---|---|---|---|---|---|---|---|---|---|---|
| 3.62 | 2.77 | 2.36 | 2.70 | 1.60 | 1.06 | -21.7% | ||||
| -79.9 | +52.9 | -79.2 | ||||||||
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2021
|
31st Dec 2022
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
Remedent, Inc. specializes in the research, development and manufacturing of oral care and cosmetic dentistry products. The Company designs, develops, manufactures and distributes its cosmetic dentistry products, including a full line of professional dental products that are distributed in Europe, Asia, Middle East and the United States. The Company's operating segment consists of dental products and oral hygiene products sold by Remedent Inc., Remedent N.V., and Biotech Dental Benelux N.V. The Company offers over-the-counter (OTC) tooth whitening products. It has three primary products: River 8, a prefabricated veneer; its custom-made GlamSmile Veneers and the SmileMe mirror. The Company has developed a range of prefabricated, ready-to-use veneers that the Company has branded as River8. The Company's product in the professional oral care and cosmetic dentistry is the GlamSmile veneer. The SmileMe Mirror enables the dentist to offer patients a complete Smile Consultation.
| Last Annual | March 31st, 2020 |
| Last Interim | December 31st, 2020 |
| Incorporated | July 31, 1986 |
| Public Since | November 16, 1993 |
| No. of Shareholders: | n/a |
| No. of Employees: | 16 |
| Sector | Healthcare |
| Industry | Healthcare Equipment & Supplies |
| Index | |
| Exchange | Pink Sheets on Nasdaq |
| Shares in Issue | 19,995,969 |
| Free Float | (0.0%) |
| Eligible for |
ISAs
SIPPs
|
| Address | Zuiderlaan 1-3 box 8, GENT, 9000, Belgium |
| Web | http://www.remedent.com/ |
| Phone | +32 9 2415880 |
| Contact | () |
| Auditors | Vandelanotte Bedrijfsrevisoren |
As of 04/03/21, shares in Remedent Inc are trading at $0.151, giving the company a market capitalisation of £2.18m. This share price information is delayed by 15 minutes.
Shares in Remedent Inc are currently trading at $0.151 and the price has moved by -20.53% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Remedent Inc price has moved by -37.98% over the past year.
There are no analysts currently covering Remedent Inc.
Remedent Inc is scheduled to issue upcoming financial results on the following dates:
Remedent Inc does not currently pay a dividend.
Remedent Inc does not currently pay a dividend.
Remedent Inc does not currently pay a dividend.
To buy shares in Remedent Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in Remedent Inc are currently trading at $0.151, giving the company a market capitalisation of £2.18m.
Here are the trading details for Remedent Inc:
Based on an overall assessment of its quality, value and momentum, Remedent Inc is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We were not able to load any forecast data for Remedent Inc.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Remedent Inc. Over the past six months, the relative strength of its shares against the market has been -6.47%. At the current price of $0.151, shares in Remedent Inc are trading at -19.76% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
We were not able to find PE ratio data for Remedent Inc.
Remedent Inc's management team is headed by:
Here are the top five shareholders of Remedent Inc based on the size of their shareholding:
